With the launch of IQVIA Explorer™ at TechIQ 2026, IQVIA, a leader in healthcare intelligence, introduced this cutting-edge technology that is meant to assist life sciences companies in converting their complicated analytics initiatives to an always-on, real-time commercial intelligence process. The IQVIA Explorer™ technology combines IQVIA’s health data, analysis techniques, and automation with external data to provide commercial teams with timely and accurate decisions. The solution drastically slashes analysis times across crucial commercial functions, reducing brand market share evaluations from weeks to less than 15 minutes, target resource allocations to under an hour, and complex scenario re-evaluations to just minutes.
Read More: Inductive Introduces Beacon-2 to Automate Human Dose Predictions for Biopharma AI and Chemists
Addressing the ongoing structural shifts in healthcare, Pete Groves, EVP, AI & Technology Solutions at IQVIA, stated, “In a market defined by complexity, volatility and margin compression, improving productivity requires commercial teams to respond faster to change, execute more efficiently and deliver stronger business outcomes.” He further highlighted the core value proposition of the new platform, adding, “Our customers trust IQVIA’s data foundation and advanced analytical capabilities to understand performance today and model what may happen tomorrow. IQVIA Explorer does both, in a matter of minutes.” Ultimately, IQVIA Explorer equips pharmaceutical, biotech, and medical device manufacturers with the agile operational speed required to navigate fluctuating markets, optimize field execution, and maintain a competitive edge.
